UM

Browse/Search Results:  1-10 of 20 Help

Selected(0)Clear Items/Page:    Sort:
Comprehensive analysis of tumor microenvironment reveals prognostic ceRNA network related to immune infiltration in sarcoma Journal article
Leng Dongliang, Yang Ziy, Sun Heng, Song Chengcheng, Huang Chen, Ip Ka-U, Chen Guokai, Deng Chu-Xia, Zhang Xiaohua Douglas, Zhao Qi. Comprehensive analysis of tumor microenvironment reveals prognostic ceRNA network related to immune infiltration in sarcoma[J]. Clinical Cancer Research, 2023, 29(19), 3986-4001.
Authors:  Leng Dongliang;  Yang Ziy;  Sun Heng;  Song Chengcheng;  Huang Chen; et al.
Adobe PDF | Favorite | TC[WOS]:3 TC[Scopus]:3  IF:10.0/11.1 | Submit date:2023/08/25
MEAI: an artificial intelligence platform for predicting distant and lymph node metastases directly from primary breast cancer Journal article
Fan,Jiansong, Zhang,Lei, Lv,Tianxu, Liu,Yuan, Sun,Heng, Miao,Kai, Jiang,Chunjuan, Li,Lihua, Pan,Xiang. MEAI: an artificial intelligence platform for predicting distant and lymph node metastases directly from primary breast cancer[J]. Journal of Cancer Research and Clinical Oncology, 2023, 149(11), 9229-9241.
Authors:  Fan,Jiansong;  Zhang,Lei;  Lv,Tianxu;  Liu,Yuan;  Sun,Heng; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:2.7/3.1 | Submit date:2023/08/03
Ancillary Diagnosis  Artificial Intelligence  Digital Pathology  Lymph Node And Distant Metastasis  Primary Breast Cancer  
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective Journal article
Chen, Yu Chi, Shi, Wei, Shi, Jia Jie, Lu, Jin Jian. Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective[J]. Journal of Cancer Research and Clinical Oncology, 2022, 148(1), 1-14.
Authors:  Chen, Yu Chi;  Shi, Wei;  Shi, Jia Jie;  Lu, Jin Jian
Favorite | TC[WOS]:27 TC[Scopus]:27  IF:2.7/3.1 | Submit date:2022/02/21
Anemia  Cd47/sirpα  Immunotherapy  Macrophages  Phagocytosis Checkpoint  
Single-cell analyses reveal mechanisms of cancer stem cell maintenance and epithelial-mesenchymal transition in recurrent bladder cancer Journal article
Wang, Huanjun, Mei, Yan, Luo, Cheng, Huang, Qun, Wang, Zifeng, Lu, Guan Ming, Qin, Lili, Sun, Zhun, Huang, Chao Wen, Yang, Zhi Wen, Chen, Junxing, Yin, Weiguo, Qian, Chao Nan, Zeng, Jianming, Chen, Lingwu, Leng, Qibin, Guo1, Yan, Jia, Guangshuai. Single-cell analyses reveal mechanisms of cancer stem cell maintenance and epithelial-mesenchymal transition in recurrent bladder cancer[J]. CLINICAL CANCER RESEARCH, 2021, 27(22), 6265-6278.
Authors:  Wang, Huanjun;  Mei, Yan;  Luo, Cheng;  Huang, Qun;  Wang, Zifeng; et al.
Favorite | TC[WOS]:57 TC[Scopus]:59  IF:10.0/11.1 | Submit date:2021/12/08
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy Journal article
Yuxin Zhao, Haiyong Wang, Chengwei He. Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147(12), 3653-3664.
Authors:  Yuxin Zhao;  Haiyong Wang;  Chengwei He
Favorite | TC[WOS]:20 TC[Scopus]:19  IF:2.7/3.1 | Submit date:2021/12/08
Non-small Cell Lung Cancer  Targeted Therapy  Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor  Drug Resistance  
Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress Journal article
Qingyu Zhang, Shan Yu, Melody Man Ting Lam, Terence Chuen Wai Poon, Litao Sun, Yufei Jiao, Alice Sze Tsai Wong, Leo Tsz On Lee. Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38.
Authors:  Qingyu Zhang;  Shan Yu;  Melody Man Ting Lam;  Terence Chuen Wai Poon;  Litao Sun; et al.
Favorite | TC[WOS]:57 TC[Scopus]:52 | Submit date:2020/05/15
Angiotensin Ii  Ovarian Cancer  Spheroid Formation  Lipogenesis  Endoplasmic Reticulum Stress  
The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism Journal article
Feng, Yixiao, Wu, Mingjun, Li, Shuman, He, Xiaoqian, Tang, Jun, Peng, Weiyan, Zeng, Beilei, Deng, Chuxia, Ren, Guosheng, Xiang, Tingxiu. The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37.
Authors:  Feng, Yixiao;  Wu, Mingjun;  Li, Shuman;  He, Xiaoqian;  Tang, Jun; et al.
Favorite | TC[WOS]:16 TC[Scopus]:21 | Submit date:2019/01/17
Cygb  Glut1  Hxk2  P53  Breast Cancer  Metabolism  Glycolysis  
Immunogenomic analyses of advanced serous ovarian cancer reveal immune score is a strong prognostic factor and an indicator of chemosensitivity Journal article
Hao D., Liu J., Chen M., Li J., Wang L., Li X., Zhao Q., Di L.-J.. Immunogenomic analyses of advanced serous ovarian cancer reveal immune score is a strong prognostic factor and an indicator of chemosensitivity[J]. Clinical Cancer Research, 2018, 24(15), 3560-3571.
Authors:  Hao D.;  Liu J.;  Chen M.;  Li J.;  Wang L.; et al.
Favorite | TC[WOS]:61 TC[Scopus]:62 | Submit date:2018/12/21
Immunogenomic analyses of advanced serous ovarian cancer reveal immunoscore is a strong prognostic factor and a predictor of chemo-sensitivity Journal article
Hao, DH, Liu, JL, Chen, MC, Li, JL, Wang, L., Li, XL, Zhao, Q., Di, L.. Immunogenomic analyses of advanced serous ovarian cancer reveal immunoscore is a strong prognostic factor and a predictor of chemo-sensitivity[J]. Clinical Cancer Research, 2018, 1-13.
Authors:  Hao, DH;  Liu, JL;  Chen, MC;  Li, JL;  Wang, L.; et al.
Favorite |   IF:10.0/11.1 | Submit date:2023/08/30
Ovarian Cancer  Immunoscore  immuno therapy  immunogenomic  
Integrated analysis reveals tubal- and ovarian-originated serous ovarian cancer and predicts differential therapeutic responses Journal article
Hao D., Li J., Jia S., Meng Y., Zhang C., Wang L., Di L.-J.. Integrated analysis reveals tubal- and ovarian-originated serous ovarian cancer and predicts differential therapeutic responses[J]. Clinical Cancer Research, 2017, 23(23), 7400-7411.
Authors:  Hao D.;  Li J.;  Jia S.;  Meng Y.;  Zhang C.; et al.
Favorite | TC[WOS]:40 TC[Scopus]:44 | Submit date:2018/12/21